| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.9 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |